Impact Investing in Healthcare
During the past several years, the somewhat overlapping concepts of Impact Investing and Environmental, Social and Governance (ESG) are increasingly top of mind for everyday investors. Impact Investing refers to...
Future Forward: Health Innovators Launch Inventions Prompted by the Pandemic
Solaris Vaccines' Chief Scientific Officer, Raymond Goodrich, featured in CBSA article “Future Forward: Health Innovators Launch Inventions Prompted by the Pandemic." Click here to download the article.
VIC Fellows Spotlight: Secondra Holmes, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic
A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...
Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge
Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...
CardioWise Named Quarterfinalists at the UCSF Health Awards
The University of California San Francisco (UCSF) Health Awards has selected CardioWise, Inc. as a Quarterfinalist in the Hospital Diagnostics Category. The awards showcase the health tech industry, showcasing the best...
University Technology Licensing Part 2: Assessing the Opportunities and Negotiating Licenses
Part 2: Technology Transfer and License Terms As was described in Part I of this article [1], VIC has a systematic and thorough technology assessment process. We also have extensive experience negotiating licenses for...
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
New company advances novel vaccines to better fight COVID-19 and other pathogens FORT COLLINS, CO - VIC Technology Venture Development, LLC (VIC), announced today the formation of Colorado-based Solaris Vaccines, Inc.,...
VIC Fellows Spotlight: Evan Goldberg, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
Part 1: Opportunity Sourcing and Assessment The U.S. invests more than $120 billion in federally sponsored research funding at universities and national labs. Technology Transfer Offices (TTOs) are unique entities...
